Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlushCare vs Voxy

PlushCare
Graded #64

Higher grade

vs+12.399999999999999
Voxy
Graded #280

Lower grade

The verdict

PlushCare takes it — 74.5/100 to 62.1/100.

PlushCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlushCare +24
74
50
Dose & formulationPlushCare +13
77
64
Clinical oversightEven
82
82
Labs & monitoringPlushCare +14
77
63
FulfillmentEven
78
78
Contract termsPlushCare +21
41
20
PlushCare · left barVoxy · right bar

The numbers

MetricPlushCareVoxy
WeighScore74.5/10062.1/100
GradeCC
Scorecard rank#64#280
Semaglutide$149/mo (starting dose, compounded)$179/mo (compounded)
Tirzepatide$399/mo (starting dose, compounded)$299/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
PlushCare

Graded #64 · C

Strengths

  • Available in all 50 states
  • Appointments with US board-certified physicians, not nurse practitioners only
  • Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
  • Owned by Transcarent, a venture-backed health platform with a named corporate parent

Where it loses points

  • Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
  • GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
  • BBB complaints center on the membership cancellation process
Voxy

Graded #280 · C

Strengths

  • Names both its compounding pharmacy (VialsRX, Houston TX) and its prescribing medical group (Arora Health & Aesthetics) — most name neither
  • Publishes the full price ladder for both drugs across 1-, 3-, 6- and 12-month terms before you start the assessment
  • One price covers the provider visit, medication, injection supplies, shipping and monthly check-ins — no separate membership fee
  • True month-to-month option at $179 semaglutide / $299 tirzepatide with no commitment required
  • Free assessment with no charge to see if you qualify, and no labs required to start

Where it loses points

  • No terms of service anywhere on the site — /terms, /terms-of-service and /terms-of-use all return 404
  • No refund policy published; the only stated commitment language is 'cancel anytime'
  • Advertised 'Starting at $129/mo' is the 12-month prepay rate — month-to-month is $179 semaglutide and $299 tirzepatide
  • No public list of states served; availability depends on where affiliated providers are licensed
  • The prescribing nurse practitioner is not named — 'provider details available during your consultation'

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard